Free shipping on all orders over $ 500

QNZ

Cat. No. M2298
QNZ Structure
Synonym:

EVP4593

Size Price Availability Quantity
1mg USD 36  USD36 In stock
5mg USD 85  USD85 In stock
10mg USD 135  USD135 In stock
25mg USD 245  USD245 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

QNZ is an inhibitor of NF-κB activation with IC50 of 11 nM.

Product Citations
Chemical Information
Molecular Weight 356.42
Formula C22H20N4O
CAS Number 545380-34-5
Solubility (25°C) DMSO 5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Mohammed M H Al-Gayyar, et al. QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model

[2] S-B Zhu, et al. NF-κB inhibitor QNZ protects human chondrocyte degeneration by promoting glucose uptake through Glut4 activation

[3] Cun-Xian Shi, et al. Sevoflurane attenuates brain damage through inhibiting autophagy and apoptosis in cerebral ischemia‑reperfusion rats

[4] Vinay Shukla, et al. Inhibition of TPPP3 attenuates β-catenin/NF-κB/COX-2 signaling in endometrial stromal cells and impairs decidualization

[5] Hsi-Hsien Hsu, et al. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis

Related NF-κB Products
Narlumosbart

Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).

Ac2-26

Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury.

Mitogen-activated protein kinase 1

Mitogen-activated protein kinase 1 (MAPK1) can activate the downstream p38/NF-κB pathway.

IKKγ NBD Inhibitory Peptide

IKKγ NBD Inhibitory Peptide is a highly specific inhibitor NF-κB inhibitor.

Tripeptide-41

Tripeptide-41(CG-Lipoxyn)isa bioactive peptide withreduce fat accumulationeffect and has been reported used as a cosmetic ingredient.

  Catalog
Abmole Inhibitor Catalog




Keywords: QNZ, EVP4593 supplier, NF-κB, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.